Methodological concept
To determine the association between early migration and late revision it is necessary to match the results from the RSA review to the results of the survival review, because migration data and revision rate data are commonly reported in different studies. In other words, since there are very few studies directly addressing the relation between early migration of tibial components and late revision, it is only possible to study this relation indirectly.
In medicine, treatment effects can be studied indirectly in so called meta-analyses of indirect comparison by comparing two different treatments against a common control (Song et al. 2003) . Results of such meta-analyses are usually, but not always, similar to those of metaanalyses of direct comparison trials. This mostly depends on whether underlying assumptions are met or not. This will be elaborated on further below. The concept of indirect comparison is illustrated in appendix figure A.1. Suppose we are interested in the comparison of treatment A versus treatment C yet no studies are available that directly compare these two treatments. However, there are studies that directly compare treatment A with treatment B (study 1) and treatment C with treatment B (study 2). Then the estimate of the indirect comparison of treatment A versus C (Tac) is calculated by: Tac = Tstudy 1 -Tstudy 2 or Tac = Tab -Tbc Regarding the association between early migration and late revision, the concept is the same as that for indirect meta-analyses. However, since we are dealing with an association rather than a treatment effect, there is no common control group. Instead, we use the type of Prosthesis, Fixation method (e.g. cement or bone ingrowth) and articulating Insert (e.g. modular or non-modular):, PFI, to match migration with revision rates, as illustrated in appendix figure A.2.
Migration and revision rates are assumed to be a characteristic of a particular type of prosthesis, fixation method and articulating insert (PFI). Therefore prosthesis, fixation method and articulating insert (PFI) acts similar to the common control group (B) in indirect metaanalyses.
PFI is defined as an uniquely identifiable tibial component with uniquely identifiable fixation method and uniquely identifiable articulating insert. It should be noted that uniquely identifiable tibial component is not equal to brand name, as there are multiple tibial components with the same brand name. For instance the Miller Galante (MG) was available in at least the following different versions: The validity of the indirect comparison depends on the internal validity (methodological quality) and similarity of the included studies (Song et al. 2003) .
Internal validity
Regarding the internal validity we determined the methodological quality of the RSA studies and survival studies according to the AQUILA methodological score (Pijls et al. 2011 ). This score was used as a weight in a weighted regression model to assess how it influenced the association between early migration and late aseptic revision: studies with higher scores weighed heavier in the analyses. Table II from the manuscript shows that in the crude analysis the 5 year revision rate increases by 7.6% for every mm increase in 1-year MTPM. When survival study quality was used as a weight, the 7.6% increase/mm 1-year MTPM of the crude analysis changed to 7.4%. So, with survival study quality as a weight 7.4% is added to the revision rate for every mm increase in 1-year MTPM. When RSA study quality was used as a weight, the 7.6% increase/mm in 1-year MTPM of the crude analysis changed to 7.1%. So, with RSA study quality as a weight 7.1% is added to the revision rate for every mm increase in 1-year MTPM. In conclusion internal validity expressed as survival study quality and RSA study quality had a small effect on the association between early migration and late aseptic revision and together with on average good methodological score for the RSA and survival studies, the requirement of adequate internal validity is met.
Similarity
Regarding the similarity (external validity) of the matched RSA and survival studies we determined the match score based on similarity in age, gender, diagnosis, hospital type and continent. These items and cut off values are based on the results of a recent Delphi among an international group of 37 independent experts and were hence determined before the analyses were performed (Pijls et al. 2011) . The match score thus resembles similarity between matching RSA and survival studies and varies between 0 and 5 points. A worked example of the calculation of match scores is available further below. A higher score indicates greater similarity of the matched RSA and survival study. The match score is calculated as follows:
When the difference in mean age between matching RSA and survival study is less than 5 years they receive 1 point. When the difference is more than 5 years or unknown (mean age is not reported), they receive 0 points. Gender When the difference in percentage females between matching RSA and survival study is less than 10% they receive 1 point. When the difference is more than 10% or unknown (percentage females is not reported), they receive 0 points. Diagnosis When the difference in percentage patients with osteoarthritis between matching RSA and survival study is less than 10% they receive 1 point. When the difference is more than 10% or unknown (percentage patients with osteoarthritis is not reported), they receive 0 points.
Hospital type
The following hospital types were considered: Academic, Developer, Special institute, High volume, Public. When the matching RSA and survival study were performed in the same type of hospital they received 1 point. When they were performed in different types of hospital or the type of hospital was unknown, they received 0 points.
Continent
When the matching RSA and survival study were performed on the same continent they received 1 point. When they were performed on different continents or the continent was unknown, they received 0 points.
The match score was used as a weight in a weighted regression model to assess how it influenced the association between early migration and late aseptic revision: studies with higher scores weighed heavier in the analyses. Table II from the manuscript shows that in the crude analysis the 5 year revision rate increases by 7.6% for every mm increase in 1-year MTPM. When match score was used as a weight, the 7.6% increase/mm 1-year migration of the crude analysis remained 7.6%. In conclusion similarity expressed as match score had almost no effect on the association between early migration and late aseptic revision. Therefore the requirement of similarity is met.
Pooling of migration data and survival data
Pooling of migration data and survival data was performed for the appraisal of publication bias: the pooled results from the literature were compared with those from the national joint registries, since they do not suffer from publication bias.
Pooling of migration data
Regarding the RSA studies pooling of migration results at the level of PFI was weighed by number of tibial components in the RSA study according to the following formula:
Pooled mean 1-x = (mean 1 * N 1 + mean 2 * N 2 + … + mean x * N x ) / (N 1 + N 2+ … +N x )
The standard deviation (SD) was pooled according to weighted variation according to the following formula: Age Pooled SD 1-x = sqrt( (SD 1 *SD 1 *(N 1 -1) + SD 2 *SD 2 * (N 2 -1) + ….+ SD x *SD x *(N x -1)..) / (N 1 +N 2 +… + N x -x) ) sqrt = square root of Pooling of survival data Starting point for the meta-analysis are the revision rates at 5 years reported in each manuscript and the minimum and the maximum follow-up (min FUP , max FUP ) of patients. These quantities may be given directly but most often they will need to be estimated from the manuscript by looking at dates of accrual (if given) and from the date of submission, or perhaps publication of the manuscript. A model for the censoring mechanism based on the minimum and the maximum follow-up is assumed here for computing the number at risk and person years for each time. Let C(t) be the function that models the censoring mechanism. Based on the available information we choose the function C(t) as follows This function expresses the proportion of patients at time t that have at least t time units of follow-up. Given the number of eligible patients (n), the effective number at risk, the number of revisions at time j and the number of censored are estimated, respectively, as S j : survival at time j C j : value of the function C(t) defined in (1) at a specific time j r j : number at risk at time j d j : number of deaths at time j c j : number of censored at time j This assumes that the censored observations are distributed uniformly over the interval. Under the same assumption, from the number of patients at risk ~r j , we can define the number of person-years over interval I j , as r j = j (~r j -c j /2), where j = t j -t j-1 is the length of I j . Following the methodology described the data for each study involved in the meta-analysis have been reconstructed. A Poisson mixed model with study as random effects has been fitted to the reconstructed data, to estimate the pooled revision probability and the confidence interval at 5 years.
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Worked example
For this worked example will use the Freeman-Samuelson, metal backed, metal pegs, cemented, fixed, modular.
Matching procedure 2 RSA studies met the inclusion criteria (Adalberth et al. 2001 , Uvehammer et al. 2007 ) both of them report migration of the Freeman-Samuelson, metal backed, metal pegs, cemented, fixed, modular.
2 survival studies met the inclusion criteria (Robertsson et al. 2000 , Arora et al. 2005 ) both of them report revision rate of the Freeman-Samuelson, metal backed, metal pegs, cemented, fixed, modular.
When matching the RSA studies to the survival study we get the following 4 (2 * 2) combinations. These combination provide the x-coordinate (migration) and y-coordinate (revision) for the figures 2 and 3 of the manuscript.
Combi
Match score Regarding the similarity (external validity) of the matched RSA and survival studies we determined the match score based on similarity in age, gender, diagnosis, hospital type and continent (see above). age (1 point), because the difference in mean is less than 5 years gender (0 point), because the difference in % females is more than 10 percent diagnosis (0 points), because the difference in % OA is more than 10 percent hospital (1 point), because patients were operated in similar hospital types continent (1point), both studies are from the same continent Pooling of survival data The pooled 5 year revision of the cemented fixed bearing FS modular uses the revision rates from the 2 included studies (see above). The pooled 5 year revision aseptic loosening was 2% for the cemented fixed bearing FS modular as is shown in figure 5 of the manuscript. The results were limited to humans
